Evidence map›Paper›PMID 37462723›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2023

Adverse Health Outcomes among Rural and Urban Breast Cancer Survivors: A Population-Based Cohort Study.

Alzina Koric, Bayarmaa Mark, Chun-Pin Chang, Shane Lloyd, Mark Dodson, Vikrant G Deshmukh, Michael Newman, Ankita Date, Lisa H Gren, Christina A Porucznik and 3 more

Open access · greenAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Alzina KoricHuntsman Cancer Institute, Salt Lake City, Utah.ORCID 0000-0002-6442-0317
Bayarmaa MarkHuntsman Cancer Institute, Salt Lake City, Utah.ORCID 0000-0003-1577-6859
Chun-Pin ChangHuntsman Cancer Institute, Salt Lake City, Utah.ORCID 0000-0002-0878-997X
Shane LloydRadiation Oncology, University of Utah School of Medicine, and Huntsman Cancer Institute, Salt Lake City, Utah.ORCID 0000-0002-4235-7652
Mark DodsonIntermountain Healthcare, Salt Lake City, Utah.ORCID 0000-0001-6601-0146
Vikrant G DeshmukhUniversity of Utah Health, Salt Lake City, Utah.ORCID 0000-0001-6670-8245
Michael NewmanHuntsman Cancer Institute, Salt Lake City, Utah.ORCID 0000-0002-3147-6058
Ankita DatePedigree and Population Resource, Population Sciences, Huntsman Cancer Institute, Salt Lake City, Utah.ORCID 0000-0002-1792-9436
Lisa H GrenDivision of Public Health | Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah.ORCID 0000-0002-5868-3292
Christina A PorucznikDivision of Public Health | Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah.ORCID 0000-0003-1973-2917
Benjamin HaalandDepartment of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, Utah.ORCID 0000-0002-6270-6303
N Lynn HenryDivision of Hematology | Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.ORCID 0000-0002-4771-5930
Mia HashibeHuntsman Cancer Institute, Salt Lake City, Utah.ORCID 0000-0002-6903-2049
University of Utah · USHuntsman Cancer Institute · USUniversity of Michigan · USUtah Department of Health · USVA Salt Lake City Healthcare System · US

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI KATHARINE S ULLMAN · 1986 to 2026
$72.6M
Long-Term Adverse Outcomes Among Rural Cancer Survivors in a Population-Based CohortR01CA244326 · NCI · UNIVERSITY OF UTAH · PI CAMP, NICOLA J., HASHIBE, MIA · 2020 to 2024
$2.4M
From genomics to natural language processing: A protected environment for research computing in the health scienceS10OD021644 · OD · UNIVERSITY OF UTAH · PI CHEATHAM, THOMAS E. · 2017 to 2017
$494k
Population-based Cohort of Endometrial Cancer Survivors in UtahR21CA185811 · NCI · UNIVERSITY OF UTAH · PI HASHIBE, MIA · 2015 to 2016
$356k
Epidemiology of testicular cancer in the Utah populationR03CA159357 · NCI · UNIVERSITY OF UTAH · PI HASHIBE, MIA · 2011 to 2012
$150k
NCI NIH HHS HHSN261201800016CNCI NIH HHS HHSN261201800016INCI NIH HHS P30 CA042014NCI NIH HHS R01 CA244326NCI NIH HHS R03 CA159357NCI NIH HHS R21 CA185811NIH HHS S10 OD021644
6 · The paper itself

Abstract

backgroundLimited population-based studies have focused on breast cancer survivors in rural populations. We sought to evaluate the risk of adverse health outcomes among rural and urban breast cancer survivors and to evaluate potential predictors for the highest risk outcomes.

methodsA population-based cohort of rural and urban breast cancer survivors diagnosed between 1997 and 2017 was identified in the Utah Cancer Registry (UCR). Rural breast cancer survivors were matched on year (±1 year) and age at cancer diagnosis (±1 year) with up to 5 urban breast cancer survivors (2,359 rural breast cancer survivors; 11,748 urban breast cancer survivors). Cox proportional hazards models were used to calculate HRs with 99% confidence intervals (CI) for adverse health outcomes overall, within 5 years, and >5 years after cancer diagnosis.

resultsCompared with urban breast cancer survivors, rural breast cancer survivors had a 39% (HR, 1.39; 95% CI, 1.02-1.65) higher risk of heart failure (HF) within the 5 years of follow-up. Overall, there was no increase in the risk of other evaluated adverse health outcomes. A higher baseline body mass index and Charlson Comorbidity Index, family history of cardiovascular diseases, family history of breast cancer, and advanced cancer stage were risk factors for HF for rural and urban breast cancer survivors, with similar levels of HF risk.

conclusionsRural residence was associated with an increased risk of HF among breast cancer survivors. IMPACT: Our study highlights the need for primary preventive strategies for rural cancer survivors at risk of heart failure.

Indexed as

Breast NeoplasmsCancer SurvivorsHeart FailureCohort StudiesFemaleHumansOutcome Assessment, Health CareRural PopulationUrban Population

Identifiers

PMID37462723
PMCPMC10592280
OpenAlexW4384626992

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.